Literature DB >> 8343748

Serum screening for Down's syndrome: some women's experiences.

H Statham1, J Green.   

Abstract

OBJECTIVES: To describe the experiences of a small group of women who had positive results after serum screening for Down's syndrome.
DESIGN: Semistructured telephone interviews and correspondence with women after a positive screening result (four women) negative amniocentesis results (eight), or termination of a pregnancy with a confirmed abnormality (eight).
SUBJECTS: 20 women who contacted Support After Termination For Abnormality about their experiences of serum screening for Down's syndrome. MAIN OUTCOME MEASURES: Women's knowledge and understanding of the test; staff misconceptions; communication of results; how women coped with the diagnostic process; attitudes to the test and to termination of abnormal fetuses.
RESULTS: All women were made anxious by their positive screening test, no matter how they were told. The women's experiences suggested that medical staff were unclear about the implications of screening tests and how to interpret risk. Even after receipt of negative amniocentesis results some women remained anxious. Staff did not always recognise women's concerns while awaiting amniocentesis results.
CONCLUSIONS: The way in which serum screening is being implemented does not always meet the needs of women with positive results. Some of the problems were not specific to screening for Down's syndrome. When screening tests are introduced policies should be adopted to ensure appropriate support for participants.

Entities:  

Keywords:  Empirical Approach; Genetics and Reproduction

Mesh:

Year:  1993        PMID: 8343748      PMCID: PMC1678378          DOI: 10.1136/bmj.307.6897.174

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  10 in total

1.  The extent of Down's syndrome screening in Britain in 1991.

Authors:  N Wald; K Wald; D Smith
Journal:  Lancet       Date:  1992-08-22       Impact factor: 79.321

2.  Antenatal screening for Down's syndrome.

Authors:  K Spencer
Journal:  BMJ       Date:  1992-09-26

3.  Screening, ethics and the law.

Authors:  T M Marteau
Journal:  BMJ       Date:  1992-12-05

4.  Factors influencing the uptake of screening for open neural-tube defects and amniocentesis to test for Down's syndrome.

Authors:  T M Marteau; M Johnston; R W Shaw; J Slack
Journal:  Br J Obstet Gynaecol       Date:  1989-06

5.  Stress after amniocentesis for high serum alpha-fetoprotein concentrations.

Authors:  W Farrant
Journal:  Br Med J       Date:  1980-08-09

6.  Screening for Down's syndrome.

Authors:  T M Marteau; J Kidd; R Cook; M Johnston; S Michie; R W Shaw; J Slack
Journal:  BMJ       Date:  1988-12-03

7.  Screening, ethics, and the law.

Authors:  A Clarke; E P Parsons
Journal:  BMJ       Date:  1993-01-16

8.  Appraisal of a new scheme for prenatal screening for Down's syndrome.

Authors:  T A Sheldon; J Simpson
Journal:  BMJ       Date:  1991-05-11

9.  Antenatal maternal serum screening for Down's syndrome: results of a demonstration project.

Authors:  N J Wald; A Kennard; J W Densem; H S Cuckle; T Chard; L Butler
Journal:  BMJ       Date:  1992-08-15

10.  Value of necropsy in acquired immunodeficiency syndrome.

Authors:  M S Wilkes; A H Fortin; J C Felix; T A Godwin; W G Thompson
Journal:  Lancet       Date:  1988-07-09       Impact factor: 79.321

  10 in total
  17 in total

1.  All parents should be given leaflet outlining full details of antenatal screening.

Authors:  W M Moore
Journal:  BMJ       Date:  1999-07-24

2.  Interpretation of screening test results: scenario does not reflect day to day practice.

Authors:  Mike Divers
Journal:  BMJ       Date:  2006-08-19

3.  Using decision analysis to compare policies for antenatal screening for Down's syndrome.

Authors:  J Fletcher; N R Hicks; J D Kay; P A Boyd
Journal:  BMJ       Date:  1995-08-05

4.  Talking about disability in prenatal genetic counseling: a report of two interactive workshops.

Authors:  Jan Hodgson; Jon Weil
Journal:  J Genet Couns       Date:  2011-10-25       Impact factor: 2.537

5.  To Use or Not to Use: The Prenatal Genetic Technology/Worry Conundrum.

Authors:  R Kenen; A C Smith; C Watkins; C Zuber-Pittore
Journal:  J Genet Couns       Date:  2000-06       Impact factor: 2.537

Review 6.  Recent advances. Obstetrics.

Authors:  P Steer
Journal:  BMJ       Date:  1995-11-04

7.  Antenatal screening for Down's syndrome. The west of Scotland's screening programme.

Authors:  A Byrne; A Cameron; K McIntosh; M McNay; K Murphy
Journal:  BMJ       Date:  1993-09-11

8.  Serum screening for Down's syndrome. Informed consent is vital...

Authors:  G Waldron; E S Williams
Journal:  BMJ       Date:  1993-08-21

Review 9.  A systematic review of decision support needs of parents making child health decisions.

Authors:  Cath Jackson; Francine M Cheater; Innes Reid
Journal:  Health Expect       Date:  2008-09       Impact factor: 3.377

10.  Impact of increased risk for fetal aneuploidy on maternal mood: a prospective longitudinal study.

Authors:  Dayna L Nevay; Catriona Hippman; Angela Inglis; Arianne Albert; Jehannine Austin
Journal:  Acta Obstet Gynecol Scand       Date:  2016-08-17       Impact factor: 3.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.